Trial completion date • Trial termination • Metastases
|
PD-L1 (Programmed death ligand 1) • ER (Estrogen receptor) • PGR (Progesterone receptor) • BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset)
|
PD-L1 expression • BRCA wild-type
|
VENTANA PD-L1 (SP142) Assay
|
Tecentriq (atezolizumab) • Talzenna (talazoparib)